Computational molecular docking and virtual screening revealed promising SARS-CoV-2 drugs
The pandemic of novel coronavirus disease 2019 (COVID-19) has rampaged the world, with
more than 58.4 million confirmed cases and over 1.38 million deaths across the world by 23 …
more than 58.4 million confirmed cases and over 1.38 million deaths across the world by 23 …
Structural and molecular basis of the interaction mechanism of selected drugs towards multiple targets of SARS-CoV-2 by molecular docking and dynamic simulation …
The repurposing of FDA approved drugs is presently receiving attention for COVID-19 drug
discovery. Previous studies revealed the binding potential of several FDA-approved drugs …
discovery. Previous studies revealed the binding potential of several FDA-approved drugs …
[PDF][PDF] The molecular docking study of potential drug candidates showing anti-COVID-19 activity by exploring of therapeutic targets of SARS-CoV-2
RR Narkhede, RS Cheke, JP Ambhore… - Eurasian J. Med …, 2020 - academia.edu
Objectives: The novel human coronavirus designated severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) first emerged in late 2019 in Wuhan, China. This virus spread …
coronavirus 2 (SARS-CoV-2) first emerged in late 2019 in Wuhan, China. This virus spread …
In silico evaluation of prospective anti-COVID-19 drug candidates as potential SARS-CoV-2 main protease inhibitors
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a recently emanating
human infectious coronavirus that causes COVID-19 disease. On 11th March 2020, it has …
human infectious coronavirus that causes COVID-19 disease. On 11th March 2020, it has …
Identification of novel inhibitors for SARS-CoV-2 as therapeutic options using machine learning-based virtual screening, molecular docking and MD simulation
The new coronavirus SARS-COV-2, which emerged in late 2019 from Wuhan city of China
was regarded as causing agent of the COVID-19 pandemic. The primary protease which is …
was regarded as causing agent of the COVID-19 pandemic. The primary protease which is …
Predictive modeling and therapeutic repurposing of natural compounds against the receptor-binding domain of SARS-CoV-2
Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is a member of the
Coronaviridae family, causing major destructions to human life directly and indirectly to the …
Coronaviridae family, causing major destructions to human life directly and indirectly to the …
Molecular docking and simulation studies on SARS-CoV-2 Mpro reveals Mitoxantrone, Leucovorin, Birinapant, and Dynasore as potent drugs against COVID-19
KB Lokhande, S Doiphode, R Vyas… - Journal of Biomolecular …, 2021 - Taylor & Francis
The outbreak of novel coronavirus (COVID-19), which began from Wuhan City, Hubei,
China, and declared as a Public Health Emergency of International Concern by World …
China, and declared as a Public Health Emergency of International Concern by World …
Molecular docking studies, molecular dynamics and ADME/tox reveal therapeutic potentials of STOCK1N-69160 against papain-like protease of SARS-CoV-2
SARS-CoV-2 is a new strain of Coronavirus that caused the pneumonia outbreak in Wuhan,
China and has spread to over 200 countries of the world. It has received worldwide attention …
China and has spread to over 200 countries of the world. It has received worldwide attention …
Computational screening of antagonists against the SARS-CoV-2 (COVID-19) coronavirus by molecular docking
R Yu, L Chen, R Lan, R Shen, P Li - International journal of antimicrobial …, 2020 - Elsevier
In the current spread of novel coronavirus (SARS-CoV-2), antiviral drug discovery is of great
importance. AutoDock Vina was used to screen potential drugs by molecular docking with …
importance. AutoDock Vina was used to screen potential drugs by molecular docking with …
Virtual screening, ADMET prediction and dynamics simulation of potential compounds targeting the main protease of SARS-CoV-2
The coronavirus disease-2019 caused by a novel SARS CoV-2 virus has emerged as a
global threat. Still, no drugs are available for its treatment. The main protease is the most …
global threat. Still, no drugs are available for its treatment. The main protease is the most …
相关搜索
- sars cov 2 drugs
- protease of sars cov 2
- sars cov 2 mpro
- domain of sars cov 2
- sars cov molecular docking
- sars cov covid 19
- sars cov main protease
- sars cov dynamics simulation
- sars cov molecular dynamics
- sars cov drug candidates
- sars cov computational screening
- sars cov potent drugs
- sars cov protease inhibitors
- sars cov therapeutic potentials
- sars cov predictive modeling
- sars cov therapeutic repurposing